COX2 expression in prognosis and in prediction to endocrine therapy in early breast cancer patients

Author： Nes Johanna  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.125, Iss.3, 2011-02, pp. : 671-685

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

ERβ overexpression results in endocrine therapy resistance and poor prognosis in postmenopausal ERα-positive breast cancer patients

By          

Oncology Letters, Vol. 11, Iss. 2, 2016-01 ,pp. : 1531-1536

Spandidos Publications

Access to resources Recommend Favorite

Role of Cyclooxygenase 2 (COX-2) in Prognosis of Breast Cancer

By Jana Debarshi   Sarkar Diptendra   Ganguly Suvro   Saha Shilpi   Sa Gaurisankar   Manna Asim   Banerjee Abhirup   Mandal Syamsundar  

Indian Journal of Surgical Oncology, Vol. 5, Iss. 1, 2014-03 ,pp. : 59-65

Springer Publishing Company

Access to resources Recommend Favorite

Neoadjuvant endocrine therapy for postmenopausal patients with hormone receptor-positive early breast cancer: a new concept

By Iwata Hiroji  

Breast Cancer, Vol. 18, Iss. 2, 2011-04 ,pp. : 92-97

Springer Publishing Company

Access to resources Recommend Favorite

Correlation between estrogen receptor β expression and the curative effect of endocrine therapy in breast cancer patients

By        

Experimental and Therapeutic Medicine, Vol. 7, Iss. 6, 2014-01 ,pp. : 1568-1572

Spandidos Publications

Access to resources Recommend Favorite

Combined analysis of vascular invasion, grade, HER2 and Ki67 expression identifies early breast cancer patients with questionable benefit of systemic adjuvant therapy

By Synnestvedt Marit  

Acta Oncologica, Vol. 52, Iss. 1, 2013-01 ,pp. : 91-101

Informa Healthcare

Access to resources Recommend Favorite